Individualised selection of left‐sided breast cancer patients for proton therapy based on cost‐effectiveness

INTRODUCTION: The significantly greater cost of proton therapy compared with X‐ray therapy is frequently justified by the expected reduction in normal tissue toxicity. This is often true for indications such as paediatric and skull base cancers. However, the benefit is less clear for other more comm...

Descripción completa

Detalles Bibliográficos
Autores principales: Austin, Annabelle M., Douglass, Michael J.J., Nguyen, Giang T., Cunningham, Lisa, Le, Hien, Hu, Yvonne, Penfold, Scott N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890920/
https://www.ncbi.nlm.nih.gov/pubmed/32638527
http://dx.doi.org/10.1002/jmrs.416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890920/
https://www.ncbi.nlm.nih.gov/pubmed/32638527
http://dx.doi.org/10.1002/jmrs.416

Ejemplares similares